Why Exact Sciences Corporation Stock Rocketed Higher in August
Exact Sciences’ stock got a major boost from a partnering deal with pharma titan Pfizer last month. …read more […]
Exact Sciences’ stock got a major boost from a partnering deal with pharma titan Pfizer last month. …read more […]
Some shareholders may want the memory giant to start paying a dividend, but not this one. …read more […]
The cybersecurity specialist easily beat expectations once again on broad-based growth. …read more […]
China could turn its telecom market into a duopoly. …read more […]
Finisar (FNSR) delivered earnings and revenue surprises of 50.00% and 0.43%, respectively, for the quarter ended July 2018. Do the numbers hold clues to what lies ahead for the stock? …read more […]
A rollercoaster ride for Tesla — first shares were up earlier in the day after CEO Elon Musk retweeted a favorable sales report by InsideEVs, which said Tesla was “1st, 2nd & 3rd in August sales” among electric car automakers.
But then shares paired gains following news that short seller Andrew Left of Citron Research filed a class action lawsuit against Tesla and Elon Musk for violating federal securities laws. …read more […]
Dividend income is nice. But it’s even better when it’s growing. …read more […]
SUNNYVALE, Calif. (AP) _ Finisar Corp. (FNSR) on Thursday reported a fiscal first-quarter loss of $18.5 million, after reporting a profit in the same period a year earlier. On a per-share basis, the Sunnyvale, California-based company said it had a loss of 16 cents. The results exceeded Wall Street expectations. …read more […]
Find out which of these stocks came under the most pressure. …read more […]
The semiconductor equipment company warned of a weakening memory-chip market. …read more […]
Not everything has been great under Amazon. …read more […]
CEO Richard Liu’s arrest casts a dark shadow over the e-commerce giant’s future. …read more […]
ZURICH/BENGALURU, Sept 6 (Reuters) – New Novartis Chief Executive Vas Narasimhan has further reshaped the Swiss drugmaker, announcing on Thursday he is selling U.S. dermatology and generic pill assets to India’s Aurobindo Pharma Ltd for up to $1 billion. The deal, which comes after price pressure hurt the U.S. pills business, includes some 300 products. …read more […]
(Reuters) – Shortseller Andrew Left of Citron Research filed a securities fraud lawsuit against Tesla Inc and its Chief Executive Officer Elon Musk, alleging he had manipulated the stock price by issuing … …read more […]
U.S. Justice Department officials said on Thursday they have charged and sanctioned a North Korean man in the 2017 global WannaCry ransomware cyberattack and the 2014 cyberassault on Sony Corp. The charges, part of a strategy by the U.S. government to deter future cyberattacks by naming and shaming the alleged perpetrators, also alleged that the North Korean hacker broke into the central bank of Bangladesh in 2016, according to a criminal complaint. Park Jin Hyok worked as part of a team of hackers, also known as the Lazarus Group, to try to breach multiple other U.S. businesses, according …read more […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.